Hepatic Impairment After oral administration of just one four mg dose (2 mg hydromorphone rapid-release tablets), indicate publicity to hydromorphone (Cmax and AUC∞) is elevated 4-fold in individuals with reasonable (Kid-Pugh Team B) hepatic impairment when compared with subjects with typical